Literature DB >> 18031464

Long-term results after liver transplantation.

Robert Pfitzmann1, Natascha C Nüssler, Michael Hippler-Benscheidt, Ruth Neuhaus, Peter Neuhaus.   

Abstract

Liver transplantation (OLT) has become a successful surgical therapy for terminal liver failure. We here report about long-term results of OLT in a single center over a period of 15 years. Between 1988 and 2002, 1365 adult OLTs were performed. Mean follow-up was 103 +/- 56 months. Main indications for OLT were viral-induced cirrhosis (27.1%), alcoholic liver disease (21%), tumors (15.7%) and cholestatic liver disease (14.6%). Retransplantation was necessary in 120 (9.6%) patients because of initial nonfunction (26.9%), recurrence of underlying disease (20.2%), acute and chronic rejection (16.8%) or thrombosis of the hepatic artery (16.8%). 275 patients (22.1%) died. Causes of death included recurrence of disease (32.1%), infections (21.8%), de novo malignancies (13.5%) and cardiovascular disease (11.6%). Patient survival after OLT was 91.4%, 82.5%, 74.7% and 68.2% after 1, 5, 10 and 15 years, and graft survival was 85.8%, 75.3%, 67.3% and 61.7% after 1, 5, 10 and 15 years, respectively. Patient survival after retransplantation was 81.6%, 68.8% and 57.1% and 48.0% after 1, 5, 10 and 15 years. This analysis reveals excellent long-term results after OLT achieved in a single center.

Entities:  

Mesh:

Year:  2007        PMID: 18031464     DOI: 10.1111/j.1432-2277.2007.00596.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  13 in total

1.  Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.

Authors:  K D S Watt; R A Pedersen; W K Kremers; J K Heimbach; M R Charlton
Journal:  Am J Transplant       Date:  2010-05-10       Impact factor: 8.086

Review 2.  Orthotopic liver transplantation and what to do during follow-up: recommendations for the practitioner.

Authors:  Daniel Benten; Katharina Staufer; Martina Sterneck
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-11-25

Review 3.  Recent advances in prevention of hepatitis B recurrence after liver transplantation.

Authors:  Zhi-Feng Xi; Qiang Xia
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

4.  An experience of liver transplantation in Latin America: a medical center in Colombia.

Authors:  Oscar Santos; Mauricio Londoño; Juan Marín; Octavio Muñoz; Álvaro Mena; Carlos Guzmán; Sergio Hoyos; Juan Restrepo; María Arbeláez; Gonzalo Correa
Journal:  Colomb Med (Cali)       Date:  2015-03-30

5.  Major influence of renal function on hyperlipidemia after living donor liver transplantation.

Authors:  Qi Ling; Kai Wang; Di Lu; Hai-Jun Guo; Wen-Shi Jiang; Xiang-Xiang He; Xiao Xu; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

6.  Strategies for the prevention of recurrent hepatitis B virus infection after liver transplantation.

Authors:  Vignan Manne; Ruby M Allen; Sammy Saab
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-03

7.  Risk factors for early viral infections after liver transplantation.

Authors:  Cornelius Johannes Busch; Benedikt Hermann Siegler; Heike Werle; Christoph Lichtenstern; Thomas Bruckner; Alexandra Heininger; Arianeb Mehrabi; Karl Heinz Weiss; Markus Alexander Weigand; Marcel Hochreiter
Journal:  Langenbecks Arch Surg       Date:  2018-04-25       Impact factor: 3.445

Review 8.  Quantification of liver fibrosis in chronic hepatitis B virus infection.

Authors:  C F Jieanu; B S Ungureanu; D L Săndulescu; I A Gheonea; D R Tudorașcu; M E Ciurea; V L Purcărea
Journal:  J Med Life       Date:  2015 Jul-Sep

9.  Analysis of adult 20-year survivors after liver transplantation.

Authors:  C Dopazo; I Bilbao; L L Castells; G Sapisochin; C Moreiras; I Campos-Varela; J Echeverri; M Caralt; J L Lázaro; R Charco
Journal:  Hepatol Int       Date:  2014-09-18       Impact factor: 6.047

10.  Posttransplant metabolic syndrome.

Authors:  M Shadab Siddiqui; Richard K Sterling
Journal:  Int J Hepatol       Date:  2012-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.